Search clinical trials for: candesartan cilexetil (Atacand)
Total 198 results
-
AstraZenecaCompletedHypertensionUnited States, France, Italy, United Kingdom, Germany, Poland, Ukraine, Belgium, Puerto Rico, Denmark
-
AstraZenecaCompletedNon-diabetic Nephropathy With HypertensionKorea, Republic of
-
GlaxoSmithKlineCompletedCardiovascular DiseaseIndia
-
AstraZenecaTakedaCompleted
-
BayerCompletedHypertension, EssentialSpain, Argentina, United States, Canada, Korea, Republic of, Italy, Russian Federation, South Africa, Ukraine, Belgium, Brazil, Lithuania, United Kingdom
-
AstraZenecaCompletedHypertensionFrance, Germany, Poland, Ukraine, Belgium, Italy
-
Augusta UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
HK inno.N CorporationCompleted
-
Merck Sharp & Dohme LLCCompleted
-
TakedaCompletedHypertensionUkraine, Germany
-
HK inno.N CorporationUnknownEssential HypertensionKorea, Republic of
-
Mayo ClinicCompleted
-
Pharmtechnology LLCAltasciences Company, Inc.Completed
-
Shin Poong Pharmaceutical Co. Ltd.CompletedEssential HypertensionKorea, Republic of
-
HK inno.N CorporationCompleted
-
Slovak Academy of SciencesUnknown
-
AstraZenecaTakedaCompletedObservational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (SISTOLA)Heart Failure | Cohort StudyFrance
-
Kaiser PermanenteUniversity of California, DavisWithdrawnHepatitis CUnited States
-
AstraZenecaCompletedStage II HypertensionKorea, Republic of
-
Boryung Pharmaceutical Co., LtdPusan National University Hospital; Ulsan University Hospital; Daegu Catholic... and other collaboratorsCompletedHypertensionKorea, Republic of
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompleted
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyTerminatedChronic Heart Failure | High Blood B-type (or Brain) Natriuretic Peptide (BNP) LevelGermany, France, Netherlands
-
Chong Kun Dang PharmaceuticalCompletedHypertension | Congestive Heart FailureKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompleted
-
AstraZenecaCompletedHypertension | Left Ventricular HypertrophyKorea, Republic of
-
AstraZenecaCompleted
-
Huazhong University of Science and TechnologyUnknown
-
AstraZenecaScentryphar Clinical Research; Cori Analyticals; Clínica São Lucas, Hospital... and other collaboratorsCompleted
-
TakedaCompleted
-
Ullevaal University HospitalTakeda; AstraZeneca; Southern-Eastern Norway Health Authorities RHFCompleted
-
TakedaCompleted
-
HK inno.N CorporationUnknown
-
Shin Poong Pharmaceutical Co. Ltd.CompletedHealthyKorea, Republic of
-
AstraZenecaCompletedHypertensionUnited States, Hungary, Slovakia, Belgium
-
AstraZenecaCompletedPediatric HypertensionUnited States, Hungary, Slovakia, Belgium
-
AstraZenecaCompletedHypertensionRussian Federation, Latvia, Romania, Slovakia, Belgium, Malta
-
University of ArizonaTexas A&M UniversityCompletedObesity | Weight Loss | Cardiovascular Risk FactorsUnited States
-
AstraZenecaCompletedHypertensionUnited Kingdom, Germany, Sweden, Estonia, Lithuania, Poland, Ukraine, Denmark, Netherlands, France, Former Serbia and Montenegro
-
GlaxoSmithKlineCompleted
-
Norwegian University of Science and TechnologyAstraZenecaCompleted
-
TakedaCompletedType 2 Diabetes Mellitus and MicroalbuminuriaJapan
-
University of SydneyThe George Institute for Global Health, IndiaTerminatedCOVID-19 | SARS-CoV2 InfectionIndia
-
BayerCompletedHypertension, EssentialGermany
-
AbbottDatamap; ClinIntel; Catalent; NuvisanWithdrawnExocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2Germany, Spain